Literature DB >> 12231366

The registry of the international society for heart and lung transplantation: nineteenth official report-2002.

Marshall I Hertz1, David O Taylor, Elbert P Trulock, Mark M Boucek, Paul J Mohacsi, Leah B Edwards, Berkeley M Keck.   

Abstract

Mesh：

Year:  2002        PMID： 12231366     DOI： 10.1016/s1053-2498(02)00498-9

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  31 in total

1.  Prognosis after heart transplantation: transplants alone cannot be the solution for end stage heart failure.

Authors:  Ani Anyanwu; Tom Treasure
Journal:  BMJ       Date:  2003-03-08

Review 2.  Exercise after heart transplantation.

Authors:  Claudio Marconi; Mauro Marzorati
Journal:  Eur J Appl Physiol       Date:  2003-09-06       Impact factor: 3.078

3.  Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study.

Authors:  Iris Bittmann; Christian Müller; Jürgen Behr; Jan Groetzner; Lorenz Frey; Udo Löhrs
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

Review 4.  Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions.

Authors:  Clifford Chin; Daniel Bernstein
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Ventricular assist devices: destination therapy or just another stop on the road?

Authors:  Mandeep R Mehra
Journal:  Curr Heart Fail Rep       Date:  2004 Apr-May

6.  Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function.

Authors:  George Su; Maki Hodnett; Nanyan Wu; Amha Atakilit; Cynthia Kosinski; Mika Godzich; Xiao Zhu Huang; Jiyeun K Kim; James A Frank; Michael A Matthay; Dean Sheppard; Jean-François Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

7.  Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.

Authors:  Franck Saint-Marcoux; Christiane Knoop; Jean Debord; Philippe Thiry; Annick Rousseau; Marc Estenne; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

8.  Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

Authors:  Mia Hedman; Marjatta Antikainen; Christer Holmberg; Mikko Neuvonen; Michel Eichelbaum; Kari T Kivistö; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

9.  Obesity and underweight are associated with an increased risk of death after lung transplantation.

Authors:  David J Lederer; Jessie S Wilt; Frank D'Ovidio; Matthew D Bacchetta; Lori Shah; Shankari Ravichandran; Jenny Lenoir; Brenda Klein; Joshua R Sonett; Selim M Arcasoy
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

10.  Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy.

Authors:  Chelsey L King; Jennifer J Devitt; Timothy D G Lee; Camille L Hancock Friesen
Journal:  J Cardiothorac Surg       Date:  2010-06-22       Impact factor: 1.637
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.